Merck Serono S.A. (Switzerland)
In research, Merck Serono S.A. (Switzerland) stands highest in Health Sciences (#6,623 of 16,688 worldwide), Medicine (#6,204 of 14,558 worldwide) and Life Sciences (#6,014 of 11,023 worldwide), over all time.
- World rank, all time
- #16,839 of 34,923
- Rank in Switzerland
- #195 of 378
- Research works
- 458 ▲ 6% vs 2018-21
- Citations
- 20k 44.2 per fractional work
- Top-10% rate
- 8.3% all institutions 10.0%
- vs its own fields
- 1.16× 1.00× is exactly expected
- Open access
- 44% world 40%
- International
- 61% world 18%
What is Merck Serono S.A. (Switzerland) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Health SciencesDomain | #6,623 of 16,688 | 14.2% | 209 | |
| MedicineField | #6,204 of 14,558 | 14.0% | 201 | |
| Life SciencesDomain | #6,014 of 11,023 | 14.1% | 170 |
Each strip is that field's whole ranked pool, with the notch where Merck Serono S.A. (Switzerland) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).
Which fields of science does Merck Serono S.A. (Switzerland) work in?
In 2022-now, 47% of research at Merck Serono S.A. (Switzerland) is in Health Sciences, 24% in Life Sciences. Its largest fields are Medicine (45%), Biochemistry, Genetics and Molecular Biology (15%), Social Sciences (6%). It does 1.8× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 24 fields, with their numbers
- Health Sciences2546.6%
- Medicine2444.5%
- Health Professions11.6%
- Veterinary00.4%
- Nursing00.1%
- Life Sciences1323.6%
- Social Sciences815.0%
- Physical Sciences814.7%
- Engineering24.4%
- Computer Science12.6%
- Materials Science12.6%
- Environmental Science11.7%
- Chemistry11.1%
- Physics and Astronomy00.9%
- Energy00.6%
- Mathematics00.6%
- Chemical Engineering00.2%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.3×. Every wedge is a field page.
All 24 fields, with their numbers
- Immunology and Microbiology4.30×2 works
- Veterinary3.00×0 works
- Biochemistry, Genetics and Molecular Biology2.84×8 works
- Pharmacology, Toxicology and Pharmaceutics2.49×0 works
- Medicine2.32×24 works
- Economics, Econometrics and Finance2.27×3 works
- Decision Sciences1.54×1 works
- Business, Management and Accounting0.74×1 works
- Materials Science0.73×1 works
- Chemistry0.68×1 works
- Energy0.67×0 works
- Agricultural and Biological Sciences0.60×2 works
- Health Professions0.60×1 works
- Chemical Engineering0.58×0 works
- Mathematics0.51×0 works
- Social Sciences0.44×3 works
- Physics and Astronomy0.41×0 works
- Computer Science0.34×1 works
- Environmental Science0.34×1 works
- Engineering0.30×2 works
- Neuroscience0.25×0 works
- Nursing0.21×0 works
- Psychology0.14×0 works
- Arts and Humanities0.10×0 works
- Immunology and Microbiology 4.3×
- Veterinary 3.0×
- Biochemistry, Genetics and Molecular Biology 2.8×
- Pharmacology, Toxicology and Pharmaceutics 2.5×
- Medicine 2.3×
- Economics, Econometrics and Finance 2.3×
- Decision Sciences 1.5×
- Business, Management and Accounting 0.7×
- Materials Science 0.7×
- Chemistry 0.7×
- Energy 0.7×
- Agricultural and Biological Sciences 0.6×
- Health Professions 0.6×
- Chemical Engineering 0.6×
- Mathematics 0.5×
- Social Sciences 0.4×
- Physics and Astronomy 0.4×
- Computer Science 0.3×
- Environmental Science 0.3×
- Engineering 0.3×
- Neuroscience 0.2×
- Nursing 0.2×
- Psychology 0.1×
- Arts and Humanities 0.1×
Who are the top researchers at Merck Serono S.A. (Switzerland)?
Ranked on the quality score, Christian Rommel, Amanda E. I. Proudfoot and Rob Hooft van Huijsduijnen lead among researchers whose main affiliation is Merck Serono S.A. (Switzerland).
- 1
Christian Rommel
Switzerland · #86,780 worldwide 14k citations · 165 works
- 2
Amanda E. I. Proudfoot
Switzerland · #119,209 worldwide 26k citations · 270 works
- 3
Rob Hooft van Huijsduijnen
Switzerland · #172,997 worldwide 9.2k citations · 99 works
- 4
Bruno E. Antonsson
Switzerland · #256,531 worldwide 16k citations · 118 works
- 5
Montserrat Camps
Switzerland · #353,845 worldwide 9.8k citations · 83 works
- 6
Thomas Rückle
Switzerland · #464,431 worldwide 4.9k citations · 68 works
- 7
Christian Chabert
Switzerland · #484,900 worldwide 4.2k citations · 29 works
- 8
Jérôme Wojcik
Switzerland · #552,853 worldwide 6.8k citations · 91 works
- 9
Jeffrey P. Shaw
Switzerland · #603,505 worldwide 3.2k citations · 36 works
- 10
Colin M. Howles
Switzerland · #792,693 worldwide 5.2k citations · 121 works
Which keywords describe research at Merck Serono S.A. (Switzerland)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Cognitive Impairment, Autoantibodies, Prognostic Factors, Biopharmaceuticals and Diagnostic Criteria.
- Self-Organization
- Genomic Aberrations
- Therapeutic Targets
- Minimal Residual Disease
- Targeted Therapy
- Innovation
- Toll-like Receptors
- Immunotherapy
- Recombinant Protein
- Stability
- Monoclonal Antibody
- Recombinant Proteins
- Antibody Engineering
- Neuromyelitis Optica
- Inflammation
- Cell Culture
- Biopharmaceuticals
- Cancer
- Autoantibodies
- Monoclonal Antibodies
- Glycosylation
- Therapeutic Antibodies
- Cognitive Impairment
- Prognostic Factors
- Diagnostic Criteria
- Immunogenicity
- Multiple Sclerosis
- Chemotherapy
- Fc Receptors
- Chromatography
- Protein Aggregation
- Mammalian Cells
- Clinical Trials
- Human Rights
- Treatment
- Rituximab
- Antiphospholipid Syndrome
- Systemic Lupus Erythematosus
- Chronic Lymphocytic Leukemia
- Liquid Crystals
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Glycosylation5▲ 83×3 topics
- Monoclonal Antibodies5▲ 98×3 topics
- Therapeutic Antibodies4▲ 113×2 topics
- Autoantibodies3▲ 22×5 topics
- Cognitive Impairment3▲ 21×3 topics
- Cancer3▲ 3.9×14 topics
- Prognostic Factors3▲ 12×8 topics
- Biopharmaceuticals3▲ 95×3 topics
- Diagnostic Criteria3▲ 20×2 topics
- Cell Culture2▲ 39×2 topics
- Immunogenicity2▲ 109×2 topics
- Inflammation2▲ 2.1×13 topics
- Multiple Sclerosis2▲ 120×1 topic
- Neuromyelitis Optica2▲ 120×1 topic
- Chemotherapy2▲ 6.0×13 topics
- Antibody Engineering2▲ 75×1 topic
- Fc Receptors2▲ 75×1 topic
- Recombinant Proteins2▲ 127×2 topics
- Chromatography2▲ 253×1 topic
- Monoclonal Antibody2▲ 71×2 topics
- Protein Aggregation2▲ 74×3 topics
- Stability2▲ 17×1 topic
- Mammalian Cells2▲ 160×1 topic
- Recombinant Protein2▲ 160×1 topic
- Clinical Trials2▲ 5.0×7 topics
- Immunotherapy2▲ 4.5×10 topics
- Human Rights2▲ 3.0×5 topics
- Toll-like Receptors2▲ 28×2 topics
- Treatment2▲ 2.5×8 topics
- Innovation2▲ 2.6×8 topics
- Rituximab2▲ 19×3 topics
- Targeted Therapy2▲ 12×5 topics
- Antiphospholipid Syndrome1▲ 52×1 topic
- Minimal Residual Disease1▲ 36×2 topics
- Systemic Lupus Erythematosus1▲ 46×1 topic
- Therapeutic Targets1▲ 15×3 topics
- Chronic Lymphocytic Leukemia1▲ 46×1 topic
- Genomic Aberrations1▲ 46×1 topic
- Liquid Crystals1▲ 119×1 topic
- Self-Organization1▲ 57×1 topic
Which research topics does Merck Serono S.A. (Switzerland) publish most on?
By volume in 2022-now: Multiple Sclerosis Research Studies, Monoclonal and Polyclonal Antibodies Research, Protein purification and stability and Viral Infectious Diseases and Gene Expression in Insects.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Multiple Sclerosis Research Studies Pathology and Forensic Medicine 2 works
- 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
- 3 Protein purification and stability Molecular Biology 2 works
- 4 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 2 works
- 5 Systemic Lupus Erythematosus Research Rheumatology 1 works
- 6 Chronic Lymphocytic Leukemia Research Genetics 1 works
- 7 Liquid Crystal Research Advancements Electronic, Optical and Magnetic Materials 1 works
- 8 Pharmaceutical Economics and Policy Economics and Econometrics 1 works
- 9 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 1 works
- 10 Growth Hormone and Insulin-like Growth Factors Endocrinology, Diabetes and Metabolism 1 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Merck Serono S.A. (Switzerland)'s research output changed?
Output in 2022-2025 was 6% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Merck Serono S.A. (Switzerland) as a percentage of every work published that year, 0.00018% in 2024.
Fractional works of Merck Serono S.A. (Switzerland) over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year, against all institutions in the same year.
Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 25.1% in 2008.
Other research institutions in Aubonne
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Merck Serono S.A. (Switzerland). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.
